Exscientia Plc Enhances Board Collaboration with Recursion
PremiumCompany AnnouncementsExscientia Plc Enhances Board Collaboration with Recursion
10d ago
Exscientia advances two additional discovery programs with Sanofi
Premium
The Fly
Exscientia advances two additional discovery programs with Sanofi
1M ago
Exscientia Set for Strategic Acquisition by Recursion
Premium
Company Announcements
Exscientia Set for Strategic Acquisition by Recursion
1M ago
Exscientia downgraded to Equal Weight from Overweight at Barclays
PremiumThe FlyExscientia downgraded to Equal Weight from Overweight at Barclays
3M ago
Is EXAI a Buy, Before Earnings?
Premium
Pre-Earnings
Is EXAI a Buy, Before Earnings?
3M ago
Exscientia Agrees to Acquisition by Recursion Pharmaceuticals
Premium
Company Announcements
Exscientia Agrees to Acquisition by Recursion Pharmaceuticals
3M ago
Exscientia pays GT Apeiron $10M upfont cash+ equity for ‘full control’ of 617
PremiumThe FlyExscientia pays GT Apeiron $10M upfont cash+ equity for ‘full control’ of 617
4M ago
Exscientia launches AWS AI-powered platform to advance drug discovery
Premium
The Fly
Exscientia launches AWS AI-powered platform to advance drug discovery
4M ago
Exscientia initiated with a Buy at TD Cowen
Premium
The Fly
Exscientia initiated with a Buy at TD Cowen
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100